The 7th Annual Miami Thyroid Oncology Symposium will be held on Friday February 28th, and Saturday March 1st, 2025
About the Symposium
Genomic and epigenomic molecular profiling have become an integrated part of cytologic evaluation of nodular thyroid disease, diagnosis and risk stratification in thyroid cancer. The traditional characterization of tumor differentiation/de-differentiation for the purposes of clinical prognostic assessments and more importantly definition/redefinition of the role of RAI treatment for individual cancer phenotypes are now being expressed by molecular characteristics. Risk stratification systems are evolving towards a theranostic model that will critically guide the initial surgical treatment and subsequent use of radioactive iodine.
The Miami Thyroid Oncology Symposium offers a platform for in depth discussions of the science of thyroid cancer diagnosis and treatment in this new paradigm. It is a unique scientific forum where practicing physicians learn how to adopt and incorporate the new diagnostic and treatment tools and techniques into their daily practice.
The MTOS 2025 is a hybrid event. Symposium will be held at the Roz & Cal Kovens Center at FIU’s Biscayne Campus. The event will be live broadcast for national and international audiences. The core faculty will be attending in person. The symposium welcomes all professionals involved or panel debates and Q&A. Technical topics will include video presentations as well.
We are committed to uphold the high-quality symposium standards we have built in the prior years. We are indebted to our world-renowned faculty for taking part in this exciting new scientific platform. We also hope to expand our attendance by reaching a larger national and international audience via the hybrid format.
